Search Results 771-780 of 19716 for Hepatitis+C

1. Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer - Mayo Clinic

   ... hepatitis B core antigen] antibody test) are eligible;; Patients positive for hepatitis C virus (HCV) antibody are eligible only if polymerase chain reaction ...

2. Robotic surgery - Doctors & Departments - Mayo Clinic

   Displaying 1-7 out of 7 doctors available. Last Name Initial: C ...

3. Publications - Michele Barnhill, M.D. - Mayo Clinic

   Immune-Checkpoint Inhibitors in the Hepatitis C-Infected Patient: To Use or Not to Use? Am J Gastroenterol 2023 Sep 1; 118 (9):1554-1555 Epub 2023 May 25

4. LEGEND Study: A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients With BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) and High-Risk NMIBC Patients Who Are BCG Naïve or Received Incomplete BCG Treatment - Mayo Clinic

   Known human immunodeficiency virus, Hepatitis B, or Hepatitis C infection. 17. Significant cardiovascular risk (e.g., coronary stenting within 8 weeks ...

5. Alumni - Center for Clinical and Translational Science

   D., Hepatitis B and hepatitis C as risk factors for hepatocellular carcinoma in Somali immigrants — Role of viral genetics/epigenetics and the immune ...

6. A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma - Mayo Clinic

   Known to be seropositive for hepatitis C (except in the setting of a sustained virologic response [SVR], defined as aviremia at least 12 weeks after completion ...

7. Treatment of IgG4-Related Disease With Revlimid and Rituximab - Mayo Clinic

   Presence of active infection that would interfere with therapy on this study, including positive serum hepatitis B surface antigen, HIV or active hepatitis C ...

8. A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia - Mayo Clinic

   Active infection with Hepatitis C Virus (HCV) (except in the setting of a sustained virologic response [SVR], defined as aviremia at least 12 weeks after ...

9. Dtap, hepatitis b, poliovirus, and haemophilus b vaccine (intramuscular route) - Side effects & uses - Mayo Clinic

   Fever over 100.4 degrees F (38 degrees C). Less common. Prolonged crying lasting more than 3 hours. Rare. Bluish lips or skin; chills; confusion; dizziness ...

10. A Study Of Obeticholic Acid Evaluating Clinical Outcomes In Patients With Primary Biliary Cirrhosis

    Hepatitis B or C virus infection; Primary sclerosing cholangitis; Alcoholic liver disease; Definite autoimmune liver disease or overlap hepatitis; Nonalcoholic ...